Consolidated Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2025	Jun. 30, 2024	Jun. 30, 2025	Jun. 30, 2024
Product sales, net	$ 2,323,466	$ 1,853,764	$ 4,555,886	$ 4,102,609
Cost of products sold	705,860	442,560	1,290,845	1,015,302
Gross profit	1,617,606	1,411,204	3,265,041	3,087,307
Selling, general and administrative expenses	3,030,952	2,868,182	6,287,680	5,903,458
Research and development expenses	51,789	314,968	420,909	409,179
Depreciation and amortization expense	19,496	8,477	38,936	20,161
Total operating expenses	3,102,237	3,191,627	6,747,525	6,332,798
Loss from operations	(1,484,631)	(1,780,423)	(3,482,484)	(3,245,491)
Interest income, net	1,521	20,966	4,788	45,505
Gain on sale of net operating losses	0	1,983,095	0	1,983,095
Loss before provision for income taxes	(1,483,110)	223,638	(3,477,696)	(1,216,891)
Provision for income taxes	0	0	0	0
Net loss	$ (1,483,110)	$ 223,638	$ (3,477,696)	$ (1,216,891)
Net loss per share applicable to common stockholders—
Basic and Diluted (in dollars per share)	$ (0.02)	$ 0	$ (0.04)	$ (0.02)
Weighted average shares outstanding and to be issued—
Basic and diluted (in shares)	82,049,984	79,966,833	81,903,323	80,412,397